Decision-making, prioritization, and overall professional responsibility for cancer treatment and its quality
The CCCC Board is responsible for decision-making, prioritization, and overall professional responsibility for cancer treatment and its quality within CCCC. Through this role, the Board supports coordinated leadership and strategic oversight of the center’s clinical activities.
The Board includes representatives from the Departments of Oncology at Rigshospitalet (RH) and Herlev and Gentofte Hospital (HGH), as well as representatives from the Danish Cancer Society (KB), the University of Copenhagen (UCPH), and the Technical University of Denmark (DTU).
The members of the CCCC board
- Lisbet Ravn; Co-chair CCCC Board, Deputy Director of HGH
- Jannik Brennum; Co-chair CCCC Board, Executive Manager/Director of Center of RH
- Lisa Sengeloev; Chief Medical Officer Oncology CCCC, HGH
- Mads Nordahl Svendsen; Chief Medical Officer Oncology CCCC, RH
- Henrik Flyger; Chief Surgical Officer Oncology CCCC, HGH
- Puk Vad Vestergaard; Chief Nursing Officer CCCC, HGH
- Katrine Bjerre Løppenthin; Chief Nursing Officer CCCC, RH
- Peter Kampmann; Chief Medical Officer Hemathology CCCC, RH
- Lisa Lyngsie Hjalgrim; Chief Medical Officer Pediatric Oncology CCCC, RH
- Morten Ziebell; Chair Oncological Health Advisory Council (SFR)
- Maria Kondrup; Senior Representative of Cancer Treatment of Zealand Region
- Jens Georg Hillingsoe; Deputy Chair Surgical Health Advisory Council (SFR)
- Katrine Rønn Kæmpe; Representative of Center for Health (CSU)
- Lisbeth Høeg-Jensen; Representative of Danish Cancer Society (KB)
- Anders Lund; Senior Research Director of Biotech Research & Innovation Center (BRIC), University of Copenhagen (KU)
- Helle Waagepetersen; Institute Director for Technical University of Denmark Health (DTU)
Read more about the CCCC board